Literature DB >> 22797202

Pattern of oestrogen, progesterone and Her2neu receptors expression in a heterogeneous carcinoma of the breast in a lactating woman.

Mohammed Naim1, Amit Kumar, Kavita Gaur, Vanesa T John.   

Abstract

Oestrogen-progestrone-Her2neu receptor status was studied in various loci/foci of heterogeneous carcinoma of the breast and its metastatic secretory component in the lymph node in a lactating woman. All the carcinoma variants were negative for the trio markers except tumour components evolved to secretory or lactating carcinoma, which showed focal positivity. Findings showed that oestrogenic receptors, progesterone receptors and Her2neu negative primitive carcinoma in a heterogenous breast cancer may evolve into oestrogen receptor, progesterone receptor and Her2neu positive secretory/lactating carcinoma alongside other receptor negative carcinoma variants. Focal marker positivity/negativity underlined the fact that a diagnostic/prognostic marker status report may account for the tumour area included in the section/sample only. Study of the immune marker expression/status in various loci may help identification of the components, morphogenesis and dynamics of heterogeneous carcinoma of the breast.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22797202      PMCID: PMC3029094          DOI: 10.1136/bcr.05.2010.3008

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  The fine structure of developing human epidermis: light, scanning, and transmission electron microscopy of the periderm.

Authors:  K A Holbrook; G F Odland
Journal:  J Invest Dermatol       Date:  1975-07       Impact factor: 8.551

2.  Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

Authors:  Chad A Livasy; Gamze Karaca; Rita Nanda; Maria S Tretiakova; Olufunmilayo I Olopade; Dominic T Moore; Charles M Perou
Journal:  Mod Pathol       Date:  2006-02       Impact factor: 7.842

3.  Validation of tissue microarray technology in breast carcinoma.

Authors:  R L Camp; L A Charette; D L Rimm
Journal:  Lab Invest       Date:  2000-12       Impact factor: 5.662

4.  Septic disruption of lactiferous ducts with heterogeneous carcinoma of the breast in a lactating woman.

Authors:  Mohammed Naim; Vanesa T John; Kavita Gaur; Afzal Anees
Journal:  BMJ Case Rep       Date:  2010-08-06

5.  Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.

Authors:  Mahmoud R Hussein; Saad R A H Abd-Elwahed; Ahmad Rezk Abdulwahed
Journal:  Cell Biol Int       Date:  2008-01-25       Impact factor: 3.612

6.  Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study.

Authors:  Michael J Halaska; George Pentheroudakis; Pavel Strnad; Hana Stankusova; Jiri Chod; Helena Robova; Lubos Petruzelka; Lukas Rob; Nicholas Pavlidis
Journal:  Breast J       Date:  2009-06-13       Impact factor: 2.431

7.  Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer.

Authors:  DaoHai Zhang; Manuel Salto-Tellez; Thomas Choudary Putti; Elaine Do; Evelyn Siew-Chuan Koay
Journal:  Mod Pathol       Date:  2003-01       Impact factor: 7.842

8.  Risk factors for triple-negative breast cancer in women under the age of 45 years.

Authors:  Jessica M Dolle; Janet R Daling; Emily White; Louise A Brinton; David R Doody; Peggy L Porter; Kathleen E Malone
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.